“clinical-trials” Archives

in
Entry Author Date Location
Tocagen IPO Raises $85M to Test Gene Therapy in Brain Cancer Trials 04/13/17 San Diego
Lyndra’s Long-Acting Drug Delivery Technology Lands $23M Investment 04/13/17 Boston
FluGen Raises $2M More, Provides Update on Phase 1 Trial 04/11/17 Wisconsin
Emulate’s “Organ-on-a-Chip” Tech Picked for FDA Research Partnership 04/11/17 Boston
OncoMed Shares Sink as One Drug Fails, Bayer Kicks Back Two Others 04/10/17 San Francisco
FDA OKs 23andMe’s Direct-to-Consumer Genetic Tests, With Caution 04/06/17 San Francisco
Zavante Plans FDA Filing After Antibiotic Hits Clinical Trial Goals 04/06/17 San Diego
With Fresh Pneumonia Data, Paratek To Seek 2018 Antibiotic Approval 04/03/17 Boston
Cydan, NEA’s Orphan Drug Experiment, Pays Off in $200M Vtesse Deal 04/03/17 Boston
New Blood: Biotech CEOs Bring Fresh Experience to Houston Ecosystem 04/03/17 Texas
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
Boston Scientific to Acquire Heart Device Maker Symetis for $435M 03/30/17 Boston
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
Next Stop on Father’s Duchenne Quest: Wall Street? Solid Raises $50M 03/30/17 Boston
With FDA Approval, Genentech Drug Becomes First For Severe MS Cases 03/29/17 San Francisco
With New Data, Vertex Touts Backbone Of Future Cystic Fibrosis Drugs 03/28/17 Boston
Tesaro’s Ovarian Cancer Drug Gets FDA Nod, No Diagnostic Needed 03/27/17 Boston
After $1M NEI Grant, ONL Therapeutics Closer to Clinical Trials 03/27/17 Detroit Ann Arbor
Ionis Pharma Spins Out Lipid Disorder Unit Akcea with Plans for IPO 03/27/17 Boston
BioClin Gets $30M to Back More Bladder Cancer Drug Trials 03/22/17 San Francisco
After a Clinical Trial Death, FDA OKs New Tests of Akashi’s Duchenne Drug 03/22/17 Boston
SutroVax Lands $64M From Roche, Others to Back Vaccine Studies 03/21/17 San Francisco
Waving White Flag, Cerulean Merges With Dare Bio, Sells Cancer Drugs 03/20/17 Boston
No Pain, No High: Nektar’s Opioid Drug Hits Trial Goals, Lifts Shares 03/20/17 San Francisco
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work 03/17/17 San Francisco
Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More 03/17/17 National
For $140M, PTC Gets Duchenne Drug and a Pricing Controversy from Marathon 03/16/17 New York
Proteon Therapeutics Plans Path Forward for Blood Vessel Drug 03/16/17 Boston
With FDA’s Blessing, Seres Preps New “Pivotal” Microbiome Drug Trial 03/16/17 Boston
Page 2 of 24 « previous page · next page »